IDEXX Laboratories/ US45168D1046 /
| 2024-04-18 9:59:59 PM | Chg. -0.26 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 477.79USD | -0.05% | 23,898 Turnover: 11.45 mill. |
-Bid Size: - | -Ask Size: - | 39.7 bill.USD | - | 46.98 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 10.17 USD | 25.25% |
| EPS Diluted: | 10.06 USD | 25.28% |
| Revenues per Share: | 44.06 USD | 8.48% |
| Book Value per Share: | 17.87 USD | 143.32% |
| Cash Flow per Share: | 10.91 USD | 66.58% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 3,660.95 USD | 8.72% |
| Net Income: | 845.04 USD | 24.44% |
| Operating Cash Flow: | 906.51 USD | - |
| Cash and Cash Equivalents: | 453.93 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 46.98 | 54.58 |
| P/S Ratio: | 10.84 | 12.60 |
| P/BV ratio: | 26.74 | 31.07 |
| P/CF Ratio: | 43.79 | 50.88 |
| PEG: | 1.86 | 2.16 |
| Earnings Yield: | 2.13% | 1.83% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 39.7 bill. USD | 46.12 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 83.09 mill. | |
Profitability
| Gross Profit Margin: | 59.82% |
| EBIT Margin: | 29.97% |
| Net Profit Margin: | 23.08% |
| Return on Equity: | 56.92% |
| Return on Assets: | 25.92% |
Financial Strength
| Liquidity I / Cash Ratio: | 47.70% |
| Liquidity II / Quick Ratio: | 95.78% |
| Liquidity III / Current Ratio: | 157.14% |
| Debt / Equity Ratio: | 119.59% |
| Dynam. Debt / Equity Ratio: | 195.85% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
